OMER

Omeros Corporation

There isn't enough reported data to score OMER yet.

OMER Fundamentals

MetricStatus
Unavailable
Healthy
Unavailable
Unavailable

OMER's profitability is currently healthy. There isn't enough data to rate its revenue, cash flow and balance sheet.

OMER PE Valuation

CHEAPFAIREXPENSIVE3.9x7.7x12x15x
CHEAPFAIREXPENSIVE3.9x7.7x12x15x
LevelPEPriceVs current
Cheap1x$1.76-90%
Fair5.3x$9.22-49%
Forward5.5x$17.99—
Expensive10x$17.82-1%
Current10x$17.99—

Historical ranges are pointers, not guarantees.

OMER's PE is 10x, but its earnings don't support one, so it isn't a reliable read right now.

OMER Forward outlook

MetricOutlook
Strongly improving
Returning to profit
Strong growth
--
Limited
Low

Analysts expect OMER to return to profit, with revenue growing. However, they disagree widely on these estimates.

OMER Risk to reward

ScenarioChangePrice
UpsideUnknown—
DownsideUnknown—

Calculated from the latest close: $17.99 on Nov 12.

There is not enough scenario data to assess OMER's risk to reward.

OMER Earnings Per Share

Q3 2023: $0.33Q4 2023: $-1.87Q1 2024: $-1.96Q2 2024: $-2.34Q3 2024: $-2.30Q4 2024: $-2.70Q1 2025: $-2.65Q2 2025: $-2.11Q3 2025: $-2.02Q4 2025: $-0.05Q1 2026: $1.15Q2 2026: $1.73Forward: $3.25
Q3 2023: $0.33Q4 2023: $-1.87Q1 2024: $-1.96Q2 2024: $-2.34Q3 2024: $-2.30Q4 2024: $-2.70Q1 2025: $-2.65Q2 2025: $-2.11Q3 2025: $-2.02Q4 2025: $-0.05Q1 2026: $1.15Q2 2026: $1.73Forward: $3.25
QuarterTTM EPSYoY
Forward$3.25+88%
Q2 2026$1.73+$3.84
Q1 2026$1.15+$3.80
Q4 2025-$0.05+$2.65
Q3 2025-$2.02+$0.28
Q2 2025-$2.11+$0.23
Q1 2025-$2.65-$0.69
Q4 2024-$2.70-$0.83
Q3 2024-$2.30-797%

OMER has returned to profit: it earned $1.73 per share over the past year, after losing money the year before.

OMER Quarterly Revenue

Q3 2023: --Q4 2023: --Q1 2024: --Q2 2024: --Q3 2024: --Q4 2024: --Q1 2025: --Q2 2025: --Q3 2025: --Q4 2025: --Q1 2026: $10MQ2 2026: $29M
Q3 2023: --Q4 2023: --Q1 2024: --Q2 2024: --Q3 2024: --Q4 2024: --Q1 2025: --Q2 2025: --Q3 2025: --Q4 2025: --Q1 2026: $10MQ2 2026: $29M
QuarterRevenueYoY
Q3 2021$30M+15%
Q2 2021$28.8M+113%
Q1 2021$21.1M-11%
Q4 2020$10.6M-68%
Q3 2020$26.1M-13%

OMER's revenue is growing: $29M last quarter, up 35% from the same quarter a year ago.

OMER Free Cash Flow

Q3 2023: −$33MQ4 2023: −$35MQ1 2024: −$42MQ2 2024: −$46MQ3 2024: −$32MQ4 2024: −$29MQ1 2025: −$36MQ2 2025: −$22MQ3 2025: −$18MQ4 2025: −$40MQ1 2026: −$15MQ2 2026: $4M
Q3 2023: −$33MQ4 2023: −$35MQ1 2024: −$42MQ2 2024: −$46MQ3 2024: −$32MQ4 2024: −$29MQ1 2025: −$36MQ2 2025: −$22MQ3 2025: −$18MQ4 2025: −$40MQ1 2026: −$15MQ2 2026: $4M
QuarterFree cash flowYoY
Q2 2026$4.1M+$26.1M
Q1 2026-$14.5M+$21.4M
Q4 2025-$39.8M-$10.8M
Q3 2025-$18.5M+$13.6M
Q2 2025-$22M+$24.1M
Q1 2025-$35.9M+$6M
Q4 2024-$29M+$5.9M
Q3 2024-$32.1M+$621K

OMER has burned cash in almost every quarter: −$69M over the past year, against −$119M the year before.

OMER Total Shares

Q3 2023: 63MQ4 2023: 63MQ1 2024: 59MQ2 2024: 58MQ3 2024: 58MQ4 2024: 58MQ1 2025: 58MQ2 2025: 59MQ3 2025: 66MQ4 2025: 64MQ1 2026: 90MQ2 2026: 90M
Q3 2023: 63MQ4 2023: 63MQ1 2024: 59MQ2 2024: 58MQ3 2024: 58MQ4 2024: 58MQ1 2025: 58MQ2 2025: 59MQ3 2025: 66MQ4 2025: 64MQ1 2026: 90MQ2 2026: 90M
PeriodChange %Net change
Quarterly-0.5%-491K shares
1 year+53%+31M shares
3 years+43%+26.8M shares
5 years+44%+27.3M shares
Available history+82%+40.3M shares

OMER has 90M diluted shares, up 53% from a year ago.

OMER Net Leverage

OMER Weekly Momentum

MetricValueStatus
RSI57.2Neutral
Stochastic62.7Neutral

OMER's weekly RSI is 57 (neutral) and its Stochastic is 63 (neutral).

OMER PE vs Healthcare Sector

MetricOMERSector medianRelative
PE10x26x60% below
PE %852956 pts above

OMER is trading at 10x earnings, a 60% discount to the Healthcare sector's median of 26x, though its earnings don't support one.

OMER Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$18.10.5% below
20 week MA$16.013% above
50 week MA$13.434% above
100 week MA$9.8982% above
200 week MA$7.06155% above

OMER's trend is up, with a small recent dip: it's below only its 8-week average, and 155% above its 200-week average.

OMER Yearly ROI

YearStart priceEnd priceROI
2020$15.0$14.9-0.7%
2021$14.9$7.64-49%
2022$7.64$2.54-67%
2023$2.54$3.27+29%
2024$3.27$11.7+257%
2025$11.7$15.7+35%
2026 YTD$15.7$18.0+15%

OMER's yearly returns have swung widely, from +257% in 2024 to −67% in 2022. It's up 15% so far in 2026.

Give your agent the market.

Get API key